Accelerate to discover

Homepage>Discover>Use of the iQue Screener as a versatile tool for in-vitro immunogenicity and immunotoxicity risk assessment

Back to filter

Mar 30, 2020

As the public health threat from COVID-19 and future emergent viruses continue to persist, the rapid, sensitive, and...

Mar 24, 2020

Researchers are now moving from reductionist, 2D monoculture assay models to more complex 3D cell models, such as...

Mar 16, 2020

A new technique called microangioCT imaging is being used with a novel polymerizing contrast agent that enables 3D...

Feb 25, 2020

Candida albicans is the most common fungal species of humans, residing on the skin, in the gut, and in the oral cavity...

Mar 31, 2020

Jan 29, 2020

Petra Julia Koch and Paul Zaslansky (Charité - Universitätsmedizin Berlin) will discuss the importance of 3D data in...

Jan 29, 2020

Obesity is now known to be much more than a cosmetic problem with its association with a wide plethora of diseases...

Jan 27, 2020

Bionano introduced novel and reliable molecular method for facioscapulohumeral muscular dystrophy detection and fast...

Mar 31, 2020

Dec 4, 2019

Micro-CT is a powerful tool for the longitudinal monitoring of bones to acquire bone mass and architectural changes in...

Use of the iQue Screener as a versatile tool for in-vitro immunogenicity and immunotoxicity risk assessment

Sep 29, 2015

Brecht Hoedemaekers, ImmunXperts

November 12th, 4pm BST

REGISTER NOW

Webinar

Get more info

Head of application support

Riccardo

Pasculli

+420 731 127 717

pasculli@accela.eu

Send Message

Brand profile

IntelliCyt Corporation's high throughput flow technology is the first to enable screening suspension cells, beads, microbes and mixtures.